Bone mineral metabolism and its relationship to leptin levels in survivors of childhood leukemia and lymphoma

Pediatric Hematology and Oncology

Volumn 22, Issue 6, 2005, Pages 489-498

  Yaris, Nilgün ^a   Sözen, Emin ^a   Erduran, Erol ^a   Ökten, Aysenur ^a   Örem, Asim ^a   Çakirbay, Hasim ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Bone mineral density; Childhood leukemia; Childhood lymphoma; Leptin; Osteoporosis

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DEOXYPYRIDINOLINE; DOXORUBICIN; GROWTH HORMONE; LEPTIN; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; OSTEOCALCIN; PREDNISOLONE; VINCRISTINE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; LEUKEMIA; LYMPHOMA; MALE; OSTEOPENIA; PHOSPHATE BLOOD LEVEL; PROVOCATION TEST;

ADOLESCENT; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEPTIN; LEUKEMIA; LYMPHOMA; MALE; MINERALS; OSTEOCALCIN;

EID: 24644471868     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010591002305     Document Type: Article

References (49)

1. Craft A W. Childhood cancer-mainly curable so where next? Acta Pediatr. 2000;89:386-392.
2. Meister LA, Meadows AT. Late effects of childhood cancer. Curr Probl Pediatr. 1993;23:102-131.
3. Shalet SM. Endocrine sequel of cancer therapy. Eur J Endocrinol. 1996;135:135-143.
4. Leiper AD. Osteoporosis in survivors of childhood malignancy. Eur J Cancer. 1998;34:770-772.
5. Arikoski P, Voutilainen R, Kroger H. Bone mineral density in long term survivors of childhood cancer. J Pediatr Endocrinol Metab. 2003;16 (Suppl 2):343-353.
6. Huang L, Li C. Leptin: a multifunctional hormone. Cell Res. 2000;10:81-92.
7. Rivera GK, Pui CH, Hancock ML, et al. Update of St Jude XI for childhood acute lymphoblastic leukemia. Leukemia. 1992;6:153-156.
8. Büyükpamukçu M, Sarialio_lu F, Akyüz C, Çevik N. Combined chemotheraphy in 76 children with non-Hodgkin's lymphoma excluding Burkitt lymphoma. Br J Cancer. 1987;56:625-628.
9. Murphy SB, Bowman WP, Abromowitch M, et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol. 1986;4:1732-1739.
10. World Health Organization. Measuring Change in Nutritional Status. Geneva: WHO; 1983.
11. Waterlow JC. Classification and definition of protein calorie malnutrition. Br J Med. 1972;3:566-569.
12. Gomez F, Galvan RR, Frank S, et al. Mortality in second and third degree malnuntion. J Trop Pediar. 1956;2:77-81.
13. Wheeler MD. Physical changes of puberty. Endocrinol Metab Clin North Am. 1991;20:1-14.
14. Tanyer G, Topcu M, Síklar Z, et al. Iki-onalti yasarasi sag líklí çocuklarda kemik mineral yogunlugunun degerlendirilmesi. Klin Bilimler Doktor. 1998;4:733-742.
15. Leonard MB, Propert KJ, Zemel BS, et al. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr. 1999;135:182-188.
16. Fassler ALC, Bonjour JP. Osteoporosis as a pediatric problem. Pediatr Clin North Am. 1995;42:811-824.
17. Halton JM, Atkinson SA, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr. 1995;126:557-564.
18. Atkinson SA, Halton JM, Bradley C, et al. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer. 1998;Suppl 11:35-39.
19. Crofton PM, Ahmed SF, Wade JC, et al. Effects of intensive chemotherapy on bone and collagen turnover and growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metabol. 1998;83:3121-3129.
20. Davies JH, Evans BA, Jones E, Evans WD, JJenney MEM, Gregory JW. Osteopenia excess adiposity and hyperleptinemia during 2 years of treatment for childhood acute lymphoblastic leukemia without cranial irradiation. Clin Endocrinol. 2004;60:358-365.
21. Arioski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1998;20:2134-2240.
22. Nysom K, Holm K, Michaelsen KF, et al. Bone mass treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol. 1998;16:3752-3760.
23. Kreipe RE. Bone mineral density in adolescent. Pediatr Ann. 1995;24:308-315.
24. Jilka RL. Biology of the basic multicellular unit and pathophysiology of osteoporosis. Med Pediatr Oncol. 2003;41:182-185.
25. Tomasi M, Bacciottini L, Benucci A, et al. Serum biochemical marker of bone turnover in healthy infants and children. Int J Biol Marker. 1996;11:159-164.
26. Olney RC. Regulation of bone mass by growth hormone. Med Pediatr Oncol. 2003;41:228-234.
27. Mukheijee A, Shalet SM. Growth hormone replacement therapy in children and adolescents: skeletal impact. Med Pediatr Oncol, 2003;41:235-242.
28. Rehman Q, Lane NE. Effect of glucocorticoids on bone density. Med Pediatr Oncol. 2003;41:208-211.
29. Swartz AM, Leonidas JC. Methotrexate osteopathy. Skeletal Radiol. 1984;11:13-16.
30. Mandel K, Atkinson S, Barr RD, Pencharz P. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol. 2004;22:1215-1221.
31. Argüelles B, Barrios V, Buno M, et al. Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin in children with acute lymphoblastic leukemia: a prospective study. Eur J Endocrinol. 2000;143:243-250.
32. Brennan BM, Rahim A, Blum WF, et al. Hyperleptinemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity. Clin Endocrinol. 1999;50:163-169.
33. Wallace AM, Tucker P, Williams DM, et al. Short term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukemia. Clin Endocrinol. 2003;58:770-776.
34. Siomons JP, Schols AM, Campfield LA, et al. Plasma concentration of total leptin and human lung-cancer associated cachexia. Clin Sci. 1997;93:273-277.
35. Arpaci F, Yilmaz MI, Ozet A, et al. Low serum leptin level in colon cancer patients without significant weight loss. Tumori. 2002;88:147-149.
36. Whipple T, Sharkey N, Demers L, Williams N. Leptin and skeleton. Clin Endocrinol. 2002;57:701-711.
37. Thomas T, Burguera B. Is leptin link between fat and bone mass. J Bone Mineral Res. 2002;17:1563-1569.
38. Gordeladze JO, Reseland JE. A unified model for action of leptin on bone turnover. J Cell Biochem. 2003;88:706-712.
39. Lee YJ, Park JH, Ju SK, et al. Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Lett. 2002;528:43-47.
40. Gordeladze JO, Drevon CA, Syversen U, Reseland JE. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis and mineralization: impact on differentiation markers, apoptosis and osteoclastic signaling. Cell Biochem. 2002;85:825-836.
41. Holloway W, Collier FM, Aitken C, et al. Leptin inhibits osteoclast generation. J Bone Miner Res. 2002;17:200-209.
42. Reseland JE, Gordeladz JO. Role of leptin in bone growth: central player or peripheral supporter. FEBS Lett. 2002;528:40-42.
43. Iwamoto I, Douchi T, Koksa S. Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women. Acta Obstet Gynecol Scand. 2000;79:1060-1064.
44. Zoico E, Zamboni M, Adami S. Relationship between leptin levels and bone mineral density in elderly. Clin Endocrinol. 2003;59:97-103.
45. Hadji P, Bock K, Gotschalk M, et al. The influence of serum leptin concentration on bone mass assessed by quantitative ultrasonometry in pre and postmenopausal women. Maluritas. 2003;44:141-148.
46. Ruhl CE, Everhart JE. Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res. 2002;17:1896-1903.
47. Matkovic V, Ilich JZ, Skugor M, et al. Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab. 1997;82:3239-3245.
48. Roemmich JN, Clark PA, Mantzoros CS, et al. Relationship of leptin to bone mineralization in children and adolescents. J Clin Endocrinol Metab. 2003;88:599-604.
49. Huang KC, Cheng WC, Yen RF, et al. Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female. Clin Endocrinol. 2004;61:204-208.